Medimaps Group
A Switzerland-based AI medical software developer focused on bone microarchitecture assessment and fracture risk prediction.
About Medimaps Group
A Switzerland-based AI medical software developer focused on bone microarchitecture assessment and fracture risk prediction.
Products
An AI-powered software designed for use during routine DXA bone densitometry scans to evaluate bone microarchitecture.
An AI-based software for opportunistic bone fragility assessment using routine X-rays.
A software solution currently in development intended for pre- and post-surgical bone microarchitecture assessment to support orthopedic surgeons.
A proprietary tool used for research into bone texture analysis and analysis of trabecular bone texture at different skeletal sites.
Security and compliance
As reported by Medimaps Group. Ask for audit reports before you buy.
- ISO 13485:2016 (certificate C831121)Certified
- MDSAPCertified
- FDA 510(k) (TBS Insight)Compliant
- CE MDR (TBS Reveal)Certified
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Medimaps Group